the open source VC database
Life Sciences Series C specialist VCs
2 public firms are labeled Specialist, list “Life Sciences” as a sector focus, and identify “Series C” as an entry stage. These are reported categories; review each firm’s thesis and profile before reaching out.
includes only:SpecialistLife SciencesStage: Series C
| Ascenta Capitalascentacap.com | — | $10M - $30M | — | Specialist | Life Sciences | New York | $325M Inaugural Fund | 2025 | Evan Rachlin, Lorence Kim, John Gutierrez, Leighanne Oh | info@ascentacap.com | |
| Avant Bioavant.bio | Mostly Lead | $1m – $30m$1-3m · $3M - $10M · $10M - $30M | — | Specialist | Life Sciences, Healthtech / Digital Health | New York | — | — | Daniella Kranjac, Sebastien Latapie, Ole Henrik Bang-Andreasen | https://avantbio.typeform.com/submission |
2 firms · 0 verified by VC firms themselvesopen the full database →
Every entry is reviewed by the focal team before publishing, and firms keep their own details current. Missing a firm? Add your fund. Your firm listed here? Open your profile and hit “update entry”.